This Dividend Giant Pfizer Could Turn a Boring Healthcare Allocation Into Serious IncomeThe Motley Fool • 02/24/26
US FDA Commissioner Makary says FDA supports mRNA vaccines but US taxpayers should not bear the costReuters • 02/23/26
Is Pfizer Stock the Only Big Pharma Name I'd Buy and Hold Through Any Market Crash?The Motley Fool • 02/20/26
Pfizer Targets Long-Term Oncology Growth Amid Competitive PressureZacks Investment Research • 02/19/26
Pfizer: Recovery Isn't Over, Battered Valuation Still Discounts Its Turnaround GameSeeking Alpha • 02/18/26
Pfizer's BRAFTOVI Regimen Improves Progression-Free Survival in Metastatic Colorectal CancerBusiness Wire • 02/17/26
Can Pfizer's New & Acquired Drugs Offset Its Looming Patent Cliff?Zacks Investment Research • 02/11/26